S100A4 and acute myeloid leukemia: The in vivo experiments demonstrated that AML cells with high S100A4 protein expression exhibited increased resistance to Ara-C resistance, and the inhibition of S100A4 protein expression enhanced the killing effect of Ara-C on AML tumor cells.